FOXA1 antagonizes EZH2-mediated CDKN2A repression in carcinogenesis

Biochemical and Biophysical Research Communications

Volumn 453, Issue 1, 2014, Pages 172-178

  Zhang, Yu ^a   Tong, Tanjun ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Carcinogenesis; CDKN2A; EZH2; FOXA1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HISTONE METHYLTRANSFERASE; TRANSCRIPTION FACTOR EZH2; EZH2 PROTEIN, HUMAN; FOXA1 PROTEIN, HUMAN; POLYCOMB REPRESSIVE COMPLEX 2;

ARTICLE; BINDING ASSAY; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL GROWTH; DNA BINDING; EPIGENETIC REPRESSION; EPIGENETICS; GENE EXPRESSION; IN VITRO STUDY; PROMOTER REGION; REGULATORY MECHANISM; TONGUE CARCINOMA; ANTAGONISTS AND INHIBITORS; BREAST TUMOR; CELL TRANSFORMATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; MALE; MCF 7 CELL LINE; METABOLISM; ONCOGENE RAS; PROSTATE TUMOR; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CARCINOGENESIS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; GENES, RAS; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; MALE; MCF-7 CELLS; POLYCOMB REPRESSIVE COMPLEX 2; PROSTATIC NEOPLASMS;

EID: 84908333414     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.09.092     Document Type: Article

References (27)

1. P.A. Jones, and S.B. Baylin The epigenomics of cancer Cell 128 2007 683 692
2. M. Collado, M.A. Blasco, and M. Serrano Cellular senescence in cancer and aging Cell 130 2007 223 233
3. A.P. Bracken, D. Kleine-Kohlbrecher, N. Dietrich, D. Pasini, G. Gargiulo, C. Beekman, K. Theilgaard-Monch, S. Minucci, B.T. Porse, J.C. Marine, K.H. Hansen, and K. Helin The polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells Genes Dev. 21 2007 525 530
4. R. Cao, L. Wang, H. Wang, L. Xia, H. Erdjument-Bromage, P. Tempst, R.S. Jones, and Y. Zhang Role of histone H3 lysine 27 methylation in polycomb-group silencing Science 298 2002 1039 1043
5. A. Sparmann, and M. van Lohuizen Polycomb silencers control cell fate, development and cancer Nat. Rev. Cancer 6 2006 846 856
6. Q. Li, Y. Zhang, J. Fu, L. Han, L. Xue, C. Lv, P. Wang, G. Li, and T. Tong FOXA1 mediates p16(INK4a) activation during cellular senescence EMBO J. 32 2013 858 873
7. K.M. Jozwik, and J.S. Carroll Pioneer factors in hormone-dependent cancers Nat. Rev. Cancer 12 2012 381 385
8. M. Katoh, M. Igarashi, H. Fukuda, H. Nakagama, and M. Katoh Cancer genetics and genomics of human FOX family genes Cancer Lett. 328 2013 198 206
9. L.A. Cirillo, F.R. Lin, I. Cuesta, D. Friedman, M. Jarnik, and K.S. Zaret Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4 Mol. Cell 9 2002 279 289
10. A. Hurtado, K.A. Holmes, C.S. Ross-Innes, D. Schmidt, and J.S. Carroll FOXA1 is a key determinant of estrogen receptor function and endocrine response Nat. Genet. 43 2011 27 33
11. M. Lupien, J. Eeckhoute, C.A. Meyer, Q. Wang, Y. Zhang, W. Li, J.S. Carroll, X.S. Liu, and M. Brown FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription Cell 132 2008 958 970
12. D. Wang, I. Garcia-Bassets, C. Benner, W. Li, X. Su, Y. Zhou, J. Qiu, W. Liu, M.U. Kaikkonen, K.A. Ohgi, C.K. Glass, M.G. Rosenfeld, and X.D. Fu Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA Nature 474 2011 390 394
13. Q. Wang, W. Li, Y. Zhang, X. Yuan, K. Xu, J. Yu, Z. Chen, R. Beroukhim, H. Wang, M. Lupien, T. Wu, M.M. Regan, C.A. Meyer, J.S. Carroll, A.K. Manrai, O.A. Janne, S.P. Balk, R. Mehra, B. Han, A.M. Chinnaiyan, M.A. Rubin, L. True, M. Fiorentino, C. Fiore, M. Loda, P.W. Kantoff, X.S. Liu, and M. Brown Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer Cell 138 2009 245 256
14. D.R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A.M. Chinnaiyan ONCOMINE: a cancer microarray database and integrated data-mining platform Neoplasia 6 2004 1 6
15. P.D. Bos, X.H. Zhang, C. Nadal, W. Shu, R.R. Gomis, D.X. Nguyen, A.J. Minn, M.J. van de Vijver, W.L. Gerald, J.A. Foekens, and J. Massague Genes that mediate breast cancer metastasis to the brain Nature 459 2009 1005 1009
16. S. Nanni, C. Priolo, A. Grasselli, M. D'Eletto, R. Merola, F. Moretti, M. Gallucci, P. De Carli, S. Sentinelli, A.M. Cianciulli, M. Mottolese, P. Carlini, D. Arcelli, M. Helmer-Citterich, C. Gaetano, M. Loda, A. Pontecorvi, S. Bacchetti, A. Sacchi, and A. Farsetti Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer Mol. Cancer Res. 4 2006 79 92
17. K. Tamura, M. Furihata, T. Tsunoda, S. Ashida, R. Takata, W. Obara, H. Yoshioka, Y. Daigo, Y. Nasu, H. Kumon, H. Konaka, M. Namiki, K. Tozawa, K. Kohri, N. Tanji, M. Yokoyama, T. Shimazui, H. Akaza, Y. Mizutani, T. Miki, T. Fujioka, T. Shuin, Y. Nakamura, and H. Nakagawa Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles Cancer Res. 67 2007 5117 5125
18. C.L. Estilo, P. O-charoenrat, S. Talbot, N.D. Socci, D.L. Carlson, R. Ghossein, T. Williams, Y. Yonekawa, Y. Ramanathan, J.O. Boyle, D.H. Kraus, S. Patel, A.R. Shaha, R.J. Wong, J.M. Huryn, J.P. Shah, and B. Singh Oral tongue cancer gene expression profiling: identification of novel potential prognosticators by oligonucleotide microarray analysis BMC Cancer 9 2009 11
19. V.R. Mas, D.G. Maluf, K.J. Archer, K. Yanek, X. Kong, L. Kulik, C.E. Freise, K.M. Olthoff, R.M. Ghobrial, P. McIver, and R. Fisher Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma Mol. Med. 15 2009 85 94
20. M.N. Storz, M. van de Rijn, Y.H. Kim, S. Mraz-Gernhard, R.T. Hoppe, and S. Kohler Gene expression profiles of cutaneous B cell lymphoma J. Invest. Dermatol. 120 2003 865 870
21. D. Talantov, A. Mazumder, J.X. Yu, T. Briggs, Y. Jiang, J. Backus, D. Atkins, and Y. Wang Novel genes associated with malignant melanoma but not benign melanocytic lesions Clin. Cancer Res. 11 2005 7234 7242
22. H. Wang, C.A. Meyer, T. Fei, G. Wang, F. Zhang, and X.S. Liu A systematic approach identifies FOXA1 as a key factor in the loss of epithelial traits during the epithelial-to-mesenchymal transition in lung cancer BMC Genomics 14 2013 680
23. Z. Li, G. Tuteja, J. Schug, and K.H. Kaestner Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer Cell 148 2012 72 83
24. C. Craig, M. Kim, E. Ohri, R. Wersto, D. Katayose, Z. Li, Y.H. Choi, B. Mudahar, S. Srivastava, P. Seth, and K. Cowan Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells Oncogene 16 1998 265 272
25. M. Serrano, A.W. Lin, M.E. McCurrach, D. Beach, and S.W. Lowe Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a Cell 88 1997 593 602
26. R. Cao, and Y. Zhang SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex Mol. Cell 15 2004 57 67
27. J. Wang, W. Bao, M. Qiu, Y. Liao, Q. Che, T. Yang, X. He, H. Qiu, and X. Wan Forkhead-box A1 suppresses the progression of endometrial cancer via crosstalk with estrogen receptor alpha Oncol. Rep. 31 2014 1225 1234